Agios Pharmaceuticals, Inc.

Connor, Clark & Lunn Investment Management Ltd. AGIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

562,642

Value ($000)

15,315

Weight

0.0%

2021 Q1 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	15,315	0.0%	562,642	12/31/2025
2025 Q3	11/13/2025	21,278	0.1%	530,098	9/30/2025
2025 Q2	8/7/2025	16,804	0.1%	505,225	6/30/2025
2025 Q1	5/12/2025	11,325	0.0%	386,523	3/31/2025
2024 Q4	2/10/2025	4,130	0.0%	125,678	12/31/2024
2024 Q3	11/8/2024	990	0.0%	22,273	9/30/2024
2024 Q2	8/9/2024	1,608	0.0%	37,281	6/30/2024
2023 Q4	2/9/2024	226	0.0%	10,131	12/31/2023
2023 Q2	8/10/2023	2,268	0.0%	80,083	6/30/2023
2023 Q1	5/10/2023	2,815	0.0%	122,534	3/31/2023
2022 Q4	2/10/2023	4,272	0.0%	152,142	12/31/2022
2022 Q3	11/10/2022	5,471	0.0%	193,475	9/30/2022
2022 Q2	8/5/2022	3,140	0.0%	141,655	6/30/2022
2022 Q1	5/12/2022	3,170	0.0%	108,888	3/31/2022
2021 Q4	2/10/2022	2,810	0.0%	85,478	12/31/2021
2021 Q3	11/12/2021	4,805	0.0%	104,123	9/30/2021
2021 Q2	8/12/2021	1,443	0.0%	26,180	6/30/2021
2021 Q1	5/13/2021	442	0.0%	8,564	3/31/2021